Skip to content

Anti-A Monoclonal

by Rapid Labs Ltd United Kingdom EUDAMED

Ref BG-A10Model Monoclonal EMDN W0103030101

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-50610272646346 Basic UDI-DIDate30 Mar 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Model / Reference
Monoclonal, BG-A10
Primary DI / UDI-DI
50610272646346, 5060599400112WX
Basic UDI-DI
B-50610272646346, B-5060599400112WX
EMDN Code
W0103030101, W0103030102
Device Class
Class IVD Annex II List A
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
GB-MF-000026335
Authorised representative
Advena Limited MT-AR-000000234

Other devices from Rapid Labs Ltd

See all devices from Rapid Labs Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (2)

  • EUDAMED 731d6f4f-e655-4e85-a82e-0d0fbaae9e87 61 fields · synced 22 Oct 2026
  • EUDAMED 5060599400112WX|B-5060599400112WX 61 fields · synced 23 Oct 2026